{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:56:27Z","timestamp":1790117787215,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-CNIG22jul-0006"],"award-info":[{"award-number":["MOH-CNIG22jul-0006"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-OFLCG18May-0002"],"award-info":[{"award-number":["MOH-OFLCG18May-0002"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-CSAINV21-0005, NMRC\/CG2\/005a\/2022-NNI"],"award-info":[{"award-number":["MOH-CSAINV21-0005, NMRC\/CG2\/005a\/2022-NNI"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SingHealth Fund\u2013 NNI Fund","award":["SHF(U)\/22\/GC-5C\/007(EC), SHF(U)\/23\/GC-2C\/002(EC)"],"award-info":[{"award-number":["SHF(U)\/22\/GC-5C\/007(EC), SHF(U)\/23\/GC-2C\/002(EC)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-026-02008-5","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T04:32:49Z","timestamp":1772685169000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluating the real-world performance of plasma pTau217 and pTau181 in a Southeast Asian tertiary memory clinic"],"prefix":"10.1186","volume":"18","author":[{"given":"Yi Jayne","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raziyeh","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Ehsan","family":"Saffari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Isabella","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis SS","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shermine HL","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis CS","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Jin","family":"Chiew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kok Pin","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahul","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon KS","family":"Ting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline SL","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"issue":"11","key":"2008_CR1","doi-asserted-by":"publisher","first-page":"4967","DOI":"10.1002\/alz.13026","volume":"19","author":"J Therriault","year":"2023","unstructured":"Therriault J, Servaes S, Tissot C, Rahmouni N, Ashton NJ, Benedet AL, et al. Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer\u2019s disease. Alzheimers Dement. 2023;19(11):4967\u201377.","journal-title":"Alzheimers Dement"},{"issue":"12","key":"2008_CR2","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1038\/s41591-022-02074-w","volume":"28","author":"NJ Ashton","year":"2022","unstructured":"Ashton NJ, Janelidze S, Mattsson-Carlgren N, Binette AP, Strandberg O, Brum WS, et al. Differential roles of A\u03b242\/40, p-tau231 and p-tau217 for Alzheimer\u2019s trial selection and disease monitoring. Nat Med. 2022;28(12):2555\u201362.","journal-title":"Nat Med"},{"issue":"3","key":"2008_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","volume":"81","author":"NJ Ashton","year":"2024","unstructured":"Ashton NJ, Brum WS, Di Molfetta G, Benedet AL, Arslan B, Jonaitis E, et al. Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology. JAMA Neurol. 2024;81(3):255.","journal-title":"JAMA Neurol"},{"key":"2008_CR4","doi-asserted-by":"publisher","first-page":"105405","DOI":"10.1016\/j.ebiom.2024.105405","volume":"109","author":"A Feizpour","year":"2024","unstructured":"Feizpour A, Doecke JD, Dor\u00e9 V, Krishnadas N, Huang K, Bourgeat P, et al. Detection and staging of Alzheimer\u2019s disease by plasma pTau217 on a high throughput immunoassay platform. eBioMedicine. 2024;109:105405.","journal-title":"eBioMedicine"},{"key":"2008_CR5","doi-asserted-by":"crossref","unstructured":"Thijssen EH, La Joie R, Strom A, Fonseca C, Iaccarino L, Wolf A, et al. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer\u2019s disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study. Lancet Neurol. 2021 Sept;20(9):739\u201352.","DOI":"10.1016\/S1474-4422(21)00214-3"},{"issue":"11","key":"2008_CR6","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1136\/jnnp-2024-333467","volume":"95","author":"S Lehmann","year":"2024","unstructured":"Lehmann S, Schraen-Maschke S, Vidal JS, Delaby C, Buee L, Blanc F, et al. Clinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairment. J Neurol Neurosurg Psychiatry. 2024;95(11):1046\u201353.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2008_CR7","doi-asserted-by":"crossref","unstructured":"Schindler SE, Galasko D, Pereira AC, Rabinovici GD, Salloway S, Su\u00e1rez-Calvet M, et al. Acceptable performance of blood biomarker tests of amyloid pathology \u2014 recommendations from the Global CEO Initiative on Alzheimer\u2019s Disease. Nat Rev Neurol. 2024 July;20(7):426\u201339.","DOI":"10.1038\/s41582-024-00977-5"},{"issue":"9","key":"2008_CR8","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/s43587-023-00471-5","volume":"3","author":"WS Brum","year":"2023","unstructured":"Brum WS, Cullen NC, Janelidze S, Ashton NJ, Zimmer ER, Therriault J, et al. A two-step workflow based on plasma p-tau217 to screen for amyloid \u03b2 positivity with further confirmatory testing only in uncertain cases. Nat Aging. 2023;3(9):1079\u201390.","journal-title":"Nat Aging"},{"key":"2008_CR9","doi-asserted-by":"crossref","unstructured":"Palmqvist S, Whitson HE, Allen LA, Suarez-Calvet M, Galasko D, Karikari TK, et al. Alzheimer\u2019s Association Clinical Practice Guideline on the use of blood\u2010based biomarkers in the diagnostic workup of suspected Alzheimer\u2019s disease within specialized care settings. Alzheimers Dement. 2025 July;21(7):e70535.","DOI":"10.1002\/alz.70535"},{"issue":"12","key":"2008_CR10","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1001\/archneur.58.12.1985","volume":"58","author":"RC Petersen","year":"2001","unstructured":"Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current Concepts in Mild Cognitive Impairment. Arch Neurol. 2001;58(12):1985.","journal-title":"Arch Neurol"},{"issue":"3","key":"2008_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):263\u20139.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"2008_CR12","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3109\/09540261.2013.763341","volume":"25","author":"K Rascovsky","year":"2013","unstructured":"Rascovsky K, Grossman M. Clinical diagnostic criteria and classification controversies in frontotemporal lobar degeneration. Int Rev Psychiatry. 2013;25(2):145\u201358.","journal-title":"Int Rev Psychiatry"},{"issue":"11","key":"2008_CR13","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","volume":"76","author":"ML Gorno-Tempini","year":"2011","unstructured":"Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76(11):1006\u201314.","journal-title":"Neurology"},{"key":"2008_CR14","doi-asserted-by":"crossref","unstructured":"Rom\u00e1n GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH et al. Vascular dementia: Diagnostic criteria for research studies: Report of the NINDS-AIREN International Workshop*. Neurology. 1993;43(2):250\u2013250.","DOI":"10.1212\/WNL.43.2.250"},{"issue":"12","key":"2008_CR15","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J, Emre M, O\u2019Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium. Neurology. 2005;65(12):1863\u201372.","journal-title":"Neurology"},{"key":"2008_CR16","doi-asserted-by":"crossref","unstructured":"Tan YJ, Ng ASL, Vipin A, Lim JKW, Chander RJ, Ji F et al. Higher Peripheral TREM2 mRNA Levels Relate to Cognitive Deficits and Hippocampal Atrophy in Alzheimer\u2019s Disease and Amnestic Mild Cognitive Impairment. Seo SW, editor. J Alzheimer\u2019s Dis. 2017;58(2):413\u201323.","DOI":"10.3233\/JAD-161277"},{"issue":"6","key":"2008_CR17","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.jalz.2013.12.023","volume":"10","author":"FH Duits","year":"2014","unstructured":"Duits FH, Teunissen CE, Bouwman FH, Visser P, Mattsson N, Zetterberg H, et al. The cerebrospinal fluid Alzheimer profile: Easily said, but what does it mean? Alzheimers Dement. 2014;10(6):713.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"2008_CR18","first-page":"e70070","volume":"17","author":"AE Mammel","year":"2025","unstructured":"Mammel AE, Hsiung GR, Mousavi A, Hallett K, Mackenzie IR, Hirsch-Reinshagen V, et al. Clinical decision points for two plasma p\u2010tau217 laboratory developed tests in neuropathology confirmed samples. Alzheimers Dement Diagn Assess Dis Monit. 2025;17(1):e70070.","journal-title":"Alzheimers Dement Diagn Assess Dis Monit"},{"issue":"8","key":"2008_CR19","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/jama.2020.12134","volume":"324","author":"S Palmqvist","year":"2020","unstructured":"Palmqvist S, Janelidze S, Quiroz YT, Zetterberg H, Lopera F, Stomrud E, et al. Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders. JAMA. 2020;324(8):772.","journal-title":"JAMA"},{"key":"2008_CR20","doi-asserted-by":"crossref","unstructured":"Arranz J, Zhu N, Rubio-Guerra S, Rodr\u00edguez-Baz \u00cd, Ferrer R, Carmona-Iragui M, et al. Diagnostic performance of plasma pTau217, pTau181, A\u03b21\u201342 and A\u03b21\u201340 in the LUMIPULSE automated platform for the detection of Alzheimer disease. Alzheimers Res Ther. 2024 June;26(1):139.","DOI":"10.1186\/s13195-024-01513-9"},{"issue":"4","key":"2008_CR21","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1093\/brain\/awac333","volume":"146","author":"S Janelidze","year":"2023","unstructured":"Janelidze S, Bali D, Ashton NJ, Barth\u00e9lemy NR, Vanbrabant J, Stoops E, et al. Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer\u2019s disease. Brain. 2023;146(4):1592\u2013601.","journal-title":"Brain"},{"key":"2008_CR22","doi-asserted-by":"crossref","unstructured":"Figdore DJ, Griswold M, Bornhorst JA, Graff-Radford J, Ramanan VK, Vemuri P, et al. Optimizing cutpoints for clinical interpretation of brain amyloid status using plasma p\u2010tau217 immunoassays. Alzheimers Dement. 2024 Sept;20(9):6506\u201316.","DOI":"10.1002\/alz.14140"},{"issue":"5","key":"2008_CR23","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1002\/alz.12841","volume":"19","author":"NJ Ashton","year":"2023","unstructured":"Ashton NJ, Puig-Pijoan A, Mil\u00e0\u2010Alom\u00e0 M, Fern\u00e1ndez\u2010Lebrero A, Garc\u00eda\u2010Escobar G, Gonz\u00e1lez\u2010Ortiz F, et al. Plasma and CSF biomarkers in a memory clinic: Head\u2010to\u2010head comparison of phosphorylated tau immunoassays. Alzheimers Dement. 2023;19(5):1913\u201324.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"2008_CR24","doi-asserted-by":"publisher","first-page":"e14565","DOI":"10.1002\/alz.14565","volume":"21","author":"Y Lin","year":"2025","unstructured":"Lin Y, Kwon HS, Lee W, Hwang M, Jeong JH, Koh S, et al. Cross-cultural validation of plasma p\u2010tau217 and p\u2010tau181 as precision biomarkers for amyloid PET positivity: An East Asian study in Taiwan and Korea. Alzheimers Dement. 2025;21(1):e14565.","journal-title":"Alzheimers Dement"},{"key":"2008_CR25","doi-asserted-by":"publisher","first-page":"105046","DOI":"10.1016\/j.ebiom.2024.105046","volume":"102","author":"J Therriault","year":"2024","unstructured":"Therriault J, Ashton NJ, Pola I, Triana-Baltzer G, Brum WS, Di Molfetta G, et al. Comparison of two plasma p-tau217 assays to detect and monitor Alzheimer\u2019s pathology. eBioMedicine. 2024;102:105046.","journal-title":"eBioMedicine"},{"issue":"5","key":"2008_CR26","doi-asserted-by":"publisher","first-page":"e17123","DOI":"10.15252\/emmm.202217123","volume":"15","author":"G Salvad\u00f3","year":"2023","unstructured":"Salvad\u00f3 G, Ossenkoppele R, Ashton NJ, Beach TG, Serrano GE, Reiman EM, et al. Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads. EMBO Mol Med. 2023;15(5):e17123.","journal-title":"EMBO Mol Med"},{"key":"2008_CR27","unstructured":"VandeVrede L, Cho H, Sanderson-Cimino M, Wekselman F, Cobigo Y, Gorno-Tempini ML et al. Detection of Alzheimer Neuropathology in Alzheimer and Non-Alzheimer Clinical Syndromes With Blood-Based Biomarkers. JAMA Neurol. 2025 Feb 10; Available from: https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2830013.Cited 14 Apr 2025."},{"key":"2008_CR28","doi-asserted-by":"crossref","unstructured":"Asken BM, DeSimone JC, Wang W, McFarland KN, Arias F, Levy S, et al. Plasma p-tau217 concordance with amyloid PET among ethnically diverse older adults. Alzheimers Dement Diagn Assess Dis Monit. 2024 July;16(3):e12617.","DOI":"10.1002\/dad2.12617"},{"key":"2008_CR29","doi-asserted-by":"crossref","unstructured":"Thanapornsangsuth P, Booncharoen K, Khieukhajee J, Luechaipanit W, Haethaisong T, Chongsuksantikul A, et al. The Bayesian approach for real-world implementation of plasma p\u2010tau217 in tertiary care memory clinics in Thailand. Alzheimers Dement. 2024 Sept;20(9):6456\u201367.","DOI":"10.1002\/alz.14138"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-026-02008-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-02008-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-02008-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T12:05:32Z","timestamp":1775822732000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-026-02008-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2008"],"URL":"https:\/\/doi.org\/10.1186\/s13195-026-02008-5","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"22 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided written informed consent through study protocols approved by Singapore Health Services Centralized Institutional Review Board (CIRB).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}